Team Leader(职位编号：008)
南京马龙医药研发有限公司
- 公司规模：少于50人
- 公司性质：外资(非欧美)
- 公司行业：制药/生物工程 学术/科研
职位信息
- 发布日期：2013-01-15
- 工作地点：南京-浦口区
- 招聘人数：1
- 工作经验：五年以上
- 学历要求：博士
- 语言要求：英语精通
- 职位类别：医药技术研发管理人员
职位描述
工作地点: 南京,浦口
最低学历 :博士
最低学历 :博士
工作性质: 全职
Responsibilities:
Responsibilities:
工作职责：
1、Research emphasis will be focused on new organic synthesis and knowledge of Chemistry Development and Technical Support.
1、Research emphasis will be focused on new organic synthesis and knowledge of Chemistry Development and Technical Support.
研究重点主要是新的有机合成，化学研发和技术支持。
2、Areas of Research will include Pharmaceutical or Organic researches etc.
研究领域包括制药或有机研究等
3. Working as the team leader and manager of all projects.
作为经理，领导团队完成各类项目
Requirements:
The successful candidate will have:
优秀的应聘者必须具有以下条件：
1. A PhD in Chemistry (Organic, Pharmaceutical)
拥有化学（有机或制药方向）博士学位。
2. We are looking for PhD with 5-10 years experience in synthesis in Chemistry Lab.
我们需要化学博士，具有5～10年化学实验室合成经验。
3. Excellent written and oral communication skills in English
3. Excellent written and oral communication skills in English
优秀的英文读写能力。
4. Experienced candidates with research background in API (Active Pharmaceutical Ingredients) or organic chemistry are preferred.
4. Experienced candidates with research background in API (Active Pharmaceutical Ingredients) or organic chemistry are preferred.
具有活性医药中间体及有机化学研究背景，经验丰富的应聘者优先。
5. Overseas experiences, working or studying, are the plus.
具有海外工作及学习经验的应聘者优先。
公司介绍
MAPI Pharma Group is a new multi national company in Israel, Germany, HK and China, and is developing a unique and novel way of tapping the API (Active Pharmaceutical Ingredient) market for Generic Pharmaceuticals, and then develops the most effective route of production, and physical form of the API production will be done in new plants in China and Germany.
MAPI Pharma Group will be one of the leading players in the API markets. Using its excellent networking in these territories, MAPI will provide generic intermediates & API's and in parallel will develop finish dosage forms either to MAPI's API's, as a vertically integrated company and generic to other leading brands. These dosage forms might be simple or complex generics like controlled release. At the beginning, MAPI will focus on intermediates & API's forms which represent about 80% of the pharmaceutical market as well as intermediate API for pharmaceuticals.
The Company will develop more than 20 new advanced generic Intermediates and API's for which their patents will expire till 2020, and also will develop new patents, as well as at an estimated rate of 2-3 new molecules per annum.
MAPI Pharma Group will be one of the leading players in the API markets. Using its excellent networking in these territories, MAPI will provide generic intermediates & API's and in parallel will develop finish dosage forms either to MAPI's API's, as a vertically integrated company and generic to other leading brands. These dosage forms might be simple or complex generics like controlled release. At the beginning, MAPI will focus on intermediates & API's forms which represent about 80% of the pharmaceutical market as well as intermediate API for pharmaceuticals.
The Company will develop more than 20 new advanced generic Intermediates and API's for which their patents will expire till 2020, and also will develop new patents, as well as at an estimated rate of 2-3 new molecules per annum.